#BEGIN_DRUGCARD DB04422

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
17588

# Chemical_Formula:
C4H9NO2S

# Chemical_IUPAC_Name:
(2S)-2-amino-4-sulfanylbutanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A thiol-containing amino acid formed by a demethylation of METHIONINE. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-Amino-4-Mercapto-Butyric Acid

# HET_ID:
HCS

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m0/s1

# InChI_Key:
InChIKey=FFFHZYDWPBMWHY-VKHMYHEASA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4422

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
135.185

# Molecular_Weight_Mono:
135.035399227

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1JQW

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.3

# Predicted_LogS:
-0.96

# Predicted_Water_Solubility:
1.48e+01 g/l

# Primary_Accession_No:
DB04422

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
91552

# PubChem_Substance_ID:
46507349

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01710

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CCS)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:18 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE000512

# Drug_Target_1_GenBank_ID_Protein:
4981844

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
metE

# Drug_Target_1_Gene_Sequence:
>2205 bp
TCAACTTTCAAATTTTTCCCTCATCTCCTTTGCAAGCGCTACCATGTTTCTGAGCGATGG
AATTACTTCGTCCCAGTTTCTCGTCTTGAGACCGCAGTCGGGATTAATCCAGATCAGCTC
CTTAGGCAGTACCCTGAGAACTCTTTCGACTATTTCCCTCATTTCGTTGATGGAGGGAAC
AGCAGGAGAGTGGATGTCCCAAACACCAACACCGATCTGCTTGATCCATCCCTTGAAATT
TTCAAAGGCAGAAATGATCTCACCTTTACTCCTCGAAGCCTCAATGCTGATCACGTCGAA
CTCCAGCTGGTGGATGTACTCAATTATTTCGTTGAAATCCGAGTAGCACATGTGGGCGTG
GATCTGTGTTTCCGGTCTCGCGTTGGCCGCCAGGTTGAAGGCGTTTATCGCCCATTCGAA
GTACTCAGGCCATTTACTCTTTTTGATGGGTGCTTTTTCTCTGAACGCGGGCTCGTCGAT
CTGCACGATTTTTATTCCCGCCTCTTCCAGATCCTTCACTTCTTCGTTTATCGCAAGGGC
TATCTGGTAGGCTATTTCTCTCTCTGGGATGTCTTCCCTGTAGTAGCTCCAGCTCATGAT
GGTGACGGGTCCTGTGAGCATTCCTTTGACGGGCTTTTCCGTGAGAGACTGAGCGTAGGT
GATTTCTTTGAGCGTCATGGGTTCTGGTCGTGTGACGGTGCCGTATATGATTGGTGGGCG
ATAACACCTCGAACCGTAGGAGAGAACCCAGCCGTTCTGAGTAGTGGCGATGCCGTTCAA
CTTCTCAGCGAAGAACTCAACCATGTCGGTTCTTTCAAACTCACCGTGCACAAGAACGTC
GAGTCCTATTTCTTCCTGAAGTTCTATAGCCTTTTTTATCTGTTCCTTTATGAAAGCTTC
ATATTCTTCTTTGGAAATTTCTCCCTTTCTGTATTTTGATCTCATCTTTCTCACTTCAGG
AGTCTGCGGGAAAGAGCCAATGGTCGTTGTTGGAAAGAGTGGAAGGTTCAGTCTTTCTCT
TTGGATTCTGTCGCGCTCGGTGTATTCTTTCTCCCTTCTGAACGAATCTTCTGGAAGATT
TCTTACCCTCTCAACAGCTTGGAGGTCCACCGCGAAATCTTCAAAAGACACGTTAGGAAG
GTCAAATGTTTTGCCTTCCAGGAAATCTTTCAACATTTTTAGCTCTTCGAGCTTTTCTTT
TGCAAAGGCAAGTTTTTCCTTCAATCCGCCTGGCAGATTGTTTTCCAGTTCCAGAGTCAC
TGGAAGATGAAAGAGTGGGCAGGAATTTGAGATGGCACTCGCACCGAGTTTTTCTACCAG
CGATGCCACCTTTCTGAGATCCACTTTCCAGGGCTGGCGGCCGTTTATCACACCAGCCAC
GAGTTTTTTGTCTTCCGGGAACCCGTGTTTTTCGAGATTTTTCAGATTTTCTTCGTTCGA
AACGAAATCGAAGTGAAGTCTCTTCACCGGAAGGGAGACGCACGCTTCGTAGTCGGAAAC
GCTGTCGTAATAGGTGAAAACAGTCAGTGGAAATTCTGAAAGCTCACGGTACACGTTCAG
TATCAGATCCCAGTGGGCCTTTTCAAGATCGCAGACGAAAGCGGGTTCGTTCACGAGAAT
CTCCTTACAGCCATTTTCCACGAGCTTTTCGAATACTTCTTTGTAAACAGAAACGAGGCT
TTCCAGCAGTTTTTCCATTTGATTTGGTCTTCTGATCCACTCGCCGTTTCTTTTGGAAAG
GTACAGGAAAGTGAAAGGACCTATCACCCACGGTGCTGTTTCTATTCCCTTCGATTTGAA
GAACAGATAATCCTCAAGAGGTTTGTTTTCGAGAAGATAGAACTCTTCGGTTTCTATTTC
CGGAACGAGGTAGTGATAGTTGGTATTGAAGAATTTGGTCATTTCCAGAGCCTTTCCACC
GCGCGCCATATCGAAGTACGTTGAAAGTCCTCTGTACTCACCGAACCTCTCCGGAACTGC
CCCCACCATCACCGCTGTGTCGAGCACAAAGTCGTAGTAGGAAAGTTCGTTTGAAGGAAT
CACATCGACGTTCTTTCTGTAGTTTTCCACCATGTACATTCTGAGTTTGTTCATCTCTTC
CTCGAACTGTTCTTCCGTGATCTTTCCCTTCCAGAAATCCTCCAGAGCCTTTTTGAATTC
CCTCTTTTCTCCTATCTTCGGAAAACCGAACGCGTAAGCCTTCAA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2941

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
85572

# Drug_Target_1_Name:
5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase

# Drug_Target_1_Number_of_Residues:
734

# Drug_Target_1_PDB_ID:
1XR2

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01717	Meth_synt_2
PF08267	Meth_synt_1

# Drug_Target_1_Protein_Sequence:
>5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MKAYAFGFPKIGEKREFKKALEDFWKGKITEEQFEEEMNKLRMYMVENYRKNVDVIPSNE
LSYYDFVLDTAVMVGAVPERFGEYRGLSTYFDMARGGKALEMTKFFNTNYHYLVPEIETE
EFYLLENKPLEDYLFFKSKGIETAPWVIGPFTFLYLSKRNGEWIRRPNQMEKLLESLVSV
YKEVFEKLVENGCKEILVNEPAFVCDLEKAHWDLILNVYRELSEFPLTVFTYYDSVSDYE
ACVSLPVKRLHFDFVSNEENLKNLEKHGFPEDKKLVAGVINGRQPWKVDLRKVASLVEKL
GASAISNSCPLFHLPVTLELENNLPGGLKEKLAFAKEKLEELKMLKDFLEGKTFDLPNVS
FEDFAVDLQAVERVRNLPEDSFRREKEYTERDRIQRERLNLPLFPTTTIGSFPQTPEVRK
MRSKYRKGEISKEEYEAFIKEQIKKAIELQEEIGLDVLVHGEFERTDMVEFFAEKLNGIA
TTQNGWVLSYGSRCYRPPIIYGTVTRPEPMTLKEITYAQSLTEKPVKGMLTGPVTIMSWS
YYREDIPEREIAYQIALAINEEVKDLEEAGIKIVQIDEPAFREKAPIKKSKWPEYFEWAI
NAFNLAANARPETQIHAHMCYSDFNEIIEYIHQLEFDVISIEASRSKGEIISAFENFKGW
IKQIGVGVWDIHSPAVPSINEMREIVERVLRVLPKELIWINPDCGLKTRNWDEVIPSLRN
MVALAKEMREKFES

# Drug_Target_1_Reaction:
5-methyltetrahydropteroyltri-L-glutamate + L-homocysteine = tetrahydropteroyltri-L-glutamate + L-methionine

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the transfer of a methyl group from 5- methyltetrahydrofolate to homocysteine resulting in methionine formation

# Drug_Target_1_SwissProt_ID:
Q9X112

# Drug_Target_1_SwissProt_Name:
METE_THEMA

# Drug_Target_1_Synonyms:
Cobalamin-independent methionine synthase
EC 2.1.1.14
Methionine synthase, vitamin-B12 independent isozyme

# Drug_Target_1_Theoretical_pI:
4.97

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AE000512

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
TM_0268

# Drug_Target_2_Gene_Sequence:
>2307 bp
TCATCTCCCAAGAGATTTCAATATTTTTACCGCTTCGGAAGCATTCTTTGCGTAATAGTC
CGCTCCAAGCTCTTTTGCTAGTTTTTCGTTCAGGGAAGCACCACCCACTATGACAGGGAT
TTTCAGGTTCTTTTCTTTGAGCTTTTCCACAACTTCCTTTATTCTGCCGACGGTGGTTGT
CATCATTGCAGACAGACCGAGTGCAACGGGTCTTTCTTTTTCCACGGCTTCCACTATTTC
CGATGTGTCCACGTCTTTTCCAAGGTCCACCACGCGGTACCCGCTGCTTCTGATGACAGA
TGCCACTATGTTCTTTCCTATGTCGTGCACATCACCCTTGACTGTTGCAATGACGAACGT
TTCACCCTGACTGTCTGATGGAAGCATCGATGTCAGTTTGTCGAACACGGGTTTCACCGT
TTGAGCGGCGAGGATGAGTTGCGGCAGAAAGATCTTTCCCTTATCGTAGAGTTCTCCAAT
ACGTTCCATCGCTGGCCTCAGGTGTTCTTCTATGACGGAAAGAGGATCTTTTTCCTTCAG
AAAATCCTCCACAAGCTTCTCGAGTTCCGACCGGTTCCCGGAGAGTATGATTTCAACCAG
TTTTTCTTCCTTCACTTCAGCCCTGGGAAGTTCCTTCTTTTCAAGTATCACAAGTGTAGC
GTTCAAGGTCTTCATTAGTGTTTCGTCGAGGGGATTCATGATGGCAGAGCTCAGGCCTTT
AGATATTCCAAGAACGAGAAAAGCGGTGTTGTAATAACTTCTGTCAGGAAGTCCGAAAGA
CAGGTTGGAAAGACCAACAGTTGTGTTGAAACCCTTGCTTGAGATGAATTCTATGGTCTT
CAGTACTTCTACCGGTTTTCCTTCTGCACCGAGGGGCAGAACTCCTGGATCGAAGATCAC
CCTGTCTGAGAAATCGTGTCTCTCCAGGATTTTCAAAGCCTTTTCGAAGTACTCTTTTCT
CTCTTCGAAGCTTTTTGGAACGTCTTTTCCCATCAATAGTACGATGAGTGTACCTCCGTA
TTTCTTCAACAGGTTTATTTTCATTTCGAGTTCTTCTTCATCCACCTTGGCCGAGTTGAA
AAGAGATCTTCCCGGATAGGCTCTGAGCGCTCTCTCTGTGAGGTCGACGTTCTGGATGTC
CAAGGAAAGAGGAACGTTCGAAACATACGGAAGTGTTTGAACGATCTTTTCCACGTATCG
TACGTCTATCTGAGATTCTATCCCGAAGTTCACATCAAGCACTTCCGCGCCTTTTTCCAC
CTGTGTTTTCGCTTCCTTGATCACAATTTCTTCGTTTCCTTTCTGCATCTCCGCCCATAG
CTTCTTTCTACCTGCCGGGTTTATCCTCTCTCCTATGACGACGAAATGATCGAACGTCAC
GAGTTTTGAAGGAGAAGAGACAGCGAATATTCTCTTTTTCTTTCTTTGAAGAGGCTTTCT
GTTTCCGAGAACTTTTCTGAAGAGCTTCACGTGTTCAGGGGTGGTTCCGCAGCAGCCTCC
GAATATGTTCACGCCGAGTTCGTAATAGGAGTCTATGTGAACGGCAAAATCGTGTGGTTT
TAAAGGATACACAGTTTTCCCGTTCTCCACGATGGGCTTTCCCGCGTTAGGTTCCACTAC
GAGAAACTTGTCTGTGTACTGGGACAGTTCCTGAAAAATGGGAAGGATCTCTTCGGGCCC
GAGTGAACAGTTTATACCGAGGGCATCGATATCCAGTTCATCGAACGTGATGGCAAAGTT
TGCGGGATCTGTCCCTGTAAGACTTCTTCCCTTCTCATCGAATGTCATGTGGGCAATCAG
GAAAACATCCCGGGATACTTCCCTTGCCGCAAGCACAGCGGCTTTCAGCTCGAGAATGTC
CGAGAACGTCTCAAAGATGATTCCGTCCACACCTTCTTCGACCATTATCTCCACGGTTTC
TCTGAAGTTCTCGTAGAATTCCTCGAACAAAGTGCTTCCGAGTGGATAGGGAAGTTCTCC
CGTCGGTCCGATATCTCCAAAAACAAGCTTTTCTCCAGCTGCTCTTCTTGCGATTCTCAC
AGCGTTTCTCACAATAGGGTCCAGTTTGTCCTCCAGCCCGTGTTTTCTCAGTTTCATCCT
TGTGGCACCGAACGTGTTCGTCAGAATGACATCCGATCCACTCTCTATGTAACTTCTATG
AACTTTCAGCACCACATCGGGTGCTTTTATATTCAGCTCTTCGGGAAGGTCATCGTATCC
GTACTTCATGAATTCTGTTCCGTAAGCACCATCTAGGAGCAACACCCTTTCTGAAAGCAA
TTTTGAAACCTCACGTCTGTTTCTCAT

# Drug_Target_2_General_Function:
Involved in calcium ion binding

# Drug_Target_2_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5668

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
85705

# Drug_Target_2_Name:
5-methyltetrahydrofolate S-homocysteine methyltransferase

# Drug_Target_2_Number_of_Residues:
768

# Drug_Target_2_PDB_ID:
1Q8J

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00809	Pterin_bind
PF02310	B12-binding
PF02574	S-methyl_trans
PF02607	B12-binding_2

# Drug_Target_2_Protein_Sequence:
>5-methyltetrahydrofolate S-homocysteine methyltransferase
MRNRREVSKLLSERVLLLDGAYGTEFMKYGYDDLPEELNIKAPDVVLKVHRSYIESGSDV
ILTNTFGATRMKLRKHGLEDKLDPIVRNAVRIARRAAGEKLVFGDIGPTGELPYPLGSTL
FEEFYENFRETVEIMVEEGVDGIIFETFSDILELKAAVLAAREVSRDVFLIAHMTFDEKG
RSLTGTDPANFAITFDELDIDALGINCSLGPEEILPIFQELSQYTDKFLVVEPNAGKPIV
ENGKTVYPLKPHDFAVHIDSYYELGVNIFGGCCGTTPEHVKLFRKVLGNRKPLQRKKKRI
FAVSSPSKLVTFDHFVVIGERINPAGRKKLWAEMQKGNEEIVIKEAKTQVEKGAEVLDVN
FGIESQIDVRYVEKIVQTLPYVSNVPLSLDIQNVDLTERALRAYPGRSLFNSAKVDEEEL
EMKINLLKKYGGTLIVLLMGKDVPKSFEERKEYFEKALKILERHDFSDRVIFDPGVLPLG
AEGKPVEVLKTIEFISSKGFNTTVGLSNLSFGLPDRSYYNTAFLVLGISKGLSSAIMNPL
DETLMKTLNATLVILEKKELPRAEVKEEKLVEIILSGNRSELEKLVEDFLKEKDPLSVIE
EHLRPAMERIGELYDKGKIFLPQLILAAQTVKPVFDKLTSMLPSDSQGETFVIATVKGDV
HDIGKNIVASVIRSSGYRVVDLGKDVDTSEIVEAVEKERPVALGLSAMMTTTVGRIKEVV
EKLKEKNLKIPVIVGGASLNEKLAKELGADYYAKNASEAVKILKSLGR

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q9WYA5

# Drug_Target_2_SwissProt_Name:
Q9WYA5_THEMA

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
5.50

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AF008220

# Drug_Target_3_GenBank_ID_Protein:
2293157

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
luxS

# Drug_Target_3_Gene_Sequence:
>474 bp
ATGCCTTCAGTAGAAAGTTTTGAGCTTGATCATAATGCGGTTGTTGCTCCATATGTAAGA
CATTGCGGCGTGCATAAAGTGGGAACAGACGGCGTTGTAAATAAATTTGACATTCGTTTT
TGCCAGCCAAATAAACAGGCGATGAAGCCTGACACCATTCACACACTCGAGCATTTGCTC
GCGTTTACGATTCGTTCTCACGCTGAGAAATACGATCATTTTGATATCATTGATATTTCT
CCAATGGGCTGCCAGACAGGCTATTATCTAGTTGTGAGCGGAGAGCCGACATCAGCGGAA
ATCGTTGATCTGCTTGAAGACACAATGAAGGAAGCGGTAGAGATTACAGAAATACCTGCT
GCGAATGAAAAGCAGTGCGGCCAAGCGAAGCTTCATGATCTGGAAGGCGCTAAACGTTTA
ATGCGTTTCTGGCTTTCACAGGATAAAGAAGAATTGCTAAAAGTATTTGGCTAA

# Drug_Target_3_General_Function:
Signal transduction mechanisms

# Drug_Target_3_General_References:
11553770	Hilgers MT, Ludwig ML: Crystal structure of the quorum-sensing protein LuxS reveals a catalytic metal site. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11169-74. Epub 2001 Sep 11.
11601850	Ruzheinikov SN, Das SK, Sedelnikova SE, Hartley A, Foster SJ, Horsburgh MJ, Cox AG, McCleod CW, Mekhalfia A, Blackburn GM, Rice DW, Baker PJ: The 1.2 A structure of a novel quorum-sensing protein, Bacillus subtilis LuxS. J Mol Biol. 2001 Oct 12;313(1):111-22.
12705835	Zhu J, Dizin E, Hu X, Wavreille AS, Park J, Pei D: S-Ribosylhomocysteinase (LuxS) is a mononuclear iron protein. Biochemistry. 2003 Apr 29;42(16):4717-26.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9387221	Lapidus A, Galleron N, Sorokin A, Ehrlich SD: Sequencing and functional annotation of the Bacillus subtilis genes in the 200 kb rrnB-dnaB region. Microbiology. 1997 Nov;143 ( Pt 11):3431-41.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2725

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
17714

# Drug_Target_3_Name:
S-ribosylhomocysteine lyase

# Drug_Target_3_Number_of_Residues:
157

# Drug_Target_3_PDB_ID:
1IE0

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF02664	LuxS

# Drug_Target_3_Protein_Sequence:
>S-ribosylhomocysteine lyase
MPSVESFELDHNAVVAPYVRHCGVHKVGTDGVVNKFDIRFCQPNKQAMKPDTIHTLEHLL
AFTIRSHAEKYDHFDIIDISPMGCQTGYYLVVSGEPTSAEIVDLLEDTMKEAVEITEIPA
ANEKQCGQAKLHDLEGAKRLMRFWLSQDKEELLKVFG

# Drug_Target_3_Reaction:
S-(5-deoxy-D-ribos-5-yl)-L-homocysteine = L-homocysteine + (4S)-4,5-dihydroxypentan-2,3-dione

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Involved in the synthesis of autoinducer 2 (AI-2) which is secreted by bacteria and is used to communicate both the cell density and the metabolic potential of the environment. The regulation of gene expression in response to changes in cell density is called quorum sensing. Catalyzes the transformation of S-ribosylhomocysteine (RHC) to homocysteine (HC) and 4,5- dihydroxy-2,3-pentadione (DPD)

# Drug_Target_3_SwissProt_ID:
O34667

# Drug_Target_3_SwissProt_Name:
LUXS_BACSU

# Drug_Target_3_Synonyms:
AI-2 synthesis protein
Autoinducer-2 production protein luxS
EC 4.4.1.21

# Drug_Target_3_Theoretical_pI:
5.25

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB04422
